The Claim
In human cerebral organoids carrying the APOE4 allele, genetic knockout of RBFOX1 induces a disease-associated microglial phenotype characterized by increased expression of CD68, TREM2, C3, IL1β, IL6, and CXCL10, resulting in neurotoxic inflammation and synaptic remodeling.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In lab-grown human brain tissue with a specific genetic variant (APOE4), removing the RBFOX1 gene causes immune-like cells to activate a harmful state that increases inflammatory markers and damages connections between brain cells.
See the scientific wording
In human cerebral organoids with the APOE4 allele, RBFOX1 knockout induces a disease-associated microglial (DAM) phenotype characterized by upregulation of CD68, TREM2, C3, and pro-inflammatory cytokines (IL1β, IL6, CXCL10), leading to neurotoxic inflammation and synaptic remodeling.
When RBFOX1 is missing in brain tissue with the APOE4 gene, immune cells called microglia form abnormally and become overactive. These microglia release inflammatory chemicals, eat away at brain connections, and cause toxic buildup of proteins and fats, which damages neurons and disrupts brain signaling.
What the research says
1 studyIn lab-grown brain tissue with the APOE4 gene, turning off RBFOX1 makes immune cells turn harmful, causing inflammation and damage to brain connections—just like in Alzheimer’s disease.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.